Hütter-Krönke, M.-L., Benner, A., Döhner, K., Krauter, J., Weber, D., Moessner, M., Köhne, C.-H., Horst, H. A., Schmidt-Wolf, I. G., Rummel, M., Götze, K., Koller, E., Petzer, A. L., Salwender, H., Fiedler, W., Kirchen, H., Haase, D., Kremers, S., Theobald, M., Matzdorff, A. C., Ganser, A., Döhner, H. and Schlenk, R. F. (2016) “Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy”, Haematologica. Pavia, Italy, 101(7), pp. 839-845. doi: 10.3324/haematol.2015.141622.